MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,064,075 | +82.5% | 370,540 | +330.1% | 0.01% | +80.0% |
| Q3 2022 | $583,000 | +176.3% | 86,151 | +62.9% | 0.01% | +150.0% |
| Q1 2022 | $211,000 | -31.0% | 52,900 | +135.1% | 0.00% | -33.3% |
| Q2 2021 | $306,000 | -58.8% | 22,500 | -51.0% | 0.00% | -66.7% |
| Q1 2021 | $743,000 | -81.8% | 45,902 | -70.1% | 0.01% | -83.6% |
| Q4 2020 | $4,080,000 | +136.5% | 153,337 | +65.5% | 0.06% | +66.7% |
| Q3 2020 | $1,725,000 | -25.5% | 92,645 | -6.3% | 0.03% | +6.5% |
| Q2 2020 | $2,314,000 | +880.5% | 98,874 | +144.1% | 0.03% | +106.7% |
| Q1 2020 | $236,000 | +293.3% | 40,507 | +285.8% | 0.02% | +1400.0% |
| Q4 2019 | $60,000 | -63.6% | 10,500 | +0.5% | 0.00% | -91.7% |
| Q1 2018 | $165,000 | -66.3% | 10,447 | -70.2% | 0.01% | -76.0% |
| Q2 2017 | $489,000 | – | 35,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |